Robertson Stephens Wealth Management, LLC
Position in CUE — Cue Biopharma, Inc.
CIK 1767307
San Francisco, CA
Position in CUE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$351,357
+$241,303 QoQ
Shares Held
11,133
-30.2% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#20
of 49 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Robertson Stephens Wealth Management, LLC holds $4,144,185 across 13 Biotechnology names. CUE ranks #5 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
14,682 | $1,028,180 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,782 | $837,465 | |
| 3 | INCY |
Incyte Corp
|
6,672 | $756,337 | |
| 4 | CTMX |
CytomX Therapeutics, Inc.
|
96,000 | $360,000 | |
| 5 | CUE |
Cue Biopharma, Inc.
This page
|
11,133 | $351,357 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
420 | $208,626 | |
| 7 | RLMD |
Relmada Therapeutics, Inc.
|
25,000 | $173,000 | |
| 8 | ACHV |
Achieve Life Sciences, Inc.
|
25,000 | $163,250 |
All Filings in CUE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $351,357 | 11,133 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $110,054 | 478,500 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $145,942 | 478,500 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $344,041 | 478,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $326,336 | 478,500 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $435,913 | 478,500 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $521,564 | 478,500 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $362,224 | 478,500 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $593,339 | 478,500 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $904,364 | 478,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,263,239 | 478,500 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,100,549 | 478,500 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,746,524 | 478,500 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,708,244 | 478,500 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,363,724 | 478,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,067,054 | 478,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,191,464 | 478,500 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,335,079 | 478,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,411,834 | 478,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,971,744 | 478,500 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,574,524 | 478,500 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $5,837,699 | 478,500 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $6,054,839 | 484,000 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $7,284,199 | 484,000 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||